Status:
UNKNOWN
The Effect of ePRO on Quality of Life and Prognosis of Patients With Unresectable Metastatic Colorectal Cancer
Lead Sponsor:
Harbin Medical University
Conditions:
Colorectal Cancer Metastatic
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bevacizumab combined with fluorouracil-based chemotherapy is the first-line standard treatment for patients with metastatic colorectal cancer (mCRC). However, some research show that the long-term sur...
Eligibility Criteria
Inclusion
- Patients must have informed consent form (ICF) signed for the study
- Patients must be ≥18 years old when signing the ICF
- Histologically or cytologically-diagnosed unresectable metastatic colorectal cancer
- Patients must receive bevacizumab combined with chemotherapy for first-line systemic treatment
- The researcher believes that the patient is capable of implementing the research protocol
Exclusion
- Patients has participated in any clinical trial in the past 4 weeks
- Patients is currently or about to participate in a clinical trial
- Patients with other malignant tumors (except carcinoma in situ)
- Patients with lung metastases only
- Patients with evidence of any serious or uncontrolled systemic disease, including but not limited to: unstable or decompensated respiratory, heart, liver or kidney disease, HIV infection, uncontrolled hypertension, diabetes, severe arrhythmia, massive hemorrhagic activity, etc
- Patients with history of alcohol or drug abuse
- According to the researcher's judgment, the possibility of inclusion is low (including inability to understand the study requirements, poor compliance, weakness, inability to ensure that the protocol can be implemented as required, etc.), or the researcher believes that other factors are not suitable for this study
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2024
Estimated Enrollment :
338 Patients enrolled
Trial Details
Trial ID
NCT04684095
Start Date
May 26 2021
End Date
June 15 2024
Last Update
July 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harbin Medical University Hospital
Harbin, China